Literature DB >> 8071972

Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy?

C Eng1, V Murday, S Seal, S Mohammed, S V Hodgson, M A Chaudary, I S Fentiman, B A Ponder, R A Eeles.   

Abstract

Cowden syndrome is an autosomal dominant condition of multiple hamartomas. Patients with this phakomatosis have an increased risk of breast cancer and thyroid tumours. Lhermitte-Duclos disease is usually a sporadic condition of cerebellar ganglion cell hypertrophy, ataxia, mental retardation, and self-limited seizure disorder. We describe a three generation family with Cowden syndrome and Lhermitte-Duclos disease. Karyotyping performed on the peripheral lymphocytes of the proband and her affected mother showed a 46,XX complement. Single strand conformational polymorphism analysis failed to show any germline p53 mutations as a cause of the syndrome in this family.

Entities:  

Mesh:

Year:  1994        PMID: 8071972      PMCID: PMC1049923          DOI: 10.1136/jmg.31.6.458

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  22 in total

1.  Cowden syndrome: clinical and pathological considerations in two new cases.

Authors:  J V Bagan; M Peñarrocha; F Vera-Sempere
Journal:  J Oral Maxillofac Surg       Date:  1989-03       Impact factor: 1.895

2.  Lhermitte-Duclos disease (granule cell hypertrophy of the cerebellum) pathological analysis of the first familial cases.

Authors:  M Ambler; S Pogacar; R Sidman
Journal:  J Neuropathol Exp Neurol       Date:  1969-10       Impact factor: 3.685

Review 3.  Clinical implications of the p53 tumor-suppressor gene.

Authors:  C C Harris; M Hollstein
Journal:  N Engl J Med       Date:  1993-10-28       Impact factor: 91.245

4.  Physical and functional interaction between WT1 and p53 proteins.

Authors:  S Maheswaran; S Park; A Bernard; J F Morris; F J Rauscher; D E Hill; D A Haber
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

5.  p53 gene mutations in human epithelial skin cancers.

Authors:  J P Molès; C Moyret; B Guillot; P Jeanteur; J J Guilhou; C Theillet; N Basset-Sèguin
Journal:  Oncogene       Date:  1993-03       Impact factor: 9.867

6.  p53 protein expression in benign and malignant skin tumours.

Authors:  Y S Ro; P N Cooper; J A Lee; A G Quinn; D Harrison; D Lane; C H Horne; J L Rees; B Angus
Journal:  Br J Dermatol       Date:  1993-03       Impact factor: 9.302

7.  Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings.

Authors:  R A Eeles; W Warren; G Knee; J Bartek; D Averill; M R Stratton; P R Blake; D M Tait; D P Lane; D F Easton
Journal:  Oncogene       Date:  1993-05       Impact factor: 9.867

8.  Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53.

Authors:  D H Mack; J Vartikar; J M Pipas; L A Laimins
Journal:  Nature       Date:  1993-05-20       Impact factor: 49.962

9.  The Cowden syndrome: a clinical and genetic study in 21 patients.

Authors:  T M Starink; J P van der Veen; F Arwert; L P de Waal; G G de Lange; J J Gille; A W Eriksson
Journal:  Clin Genet       Date:  1986-03       Impact factor: 4.438

10.  Colorectal polyps in Cowden's disease (multiple hamartoma syndrome).

Authors:  G J Carlson; S Nivatvongs; D C Snover
Journal:  Am J Surg Pathol       Date:  1984-10       Impact factor: 6.394

View more
  16 in total

1.  A role for nuclear PTEN in neuronal differentiation.

Authors:  M B Lachyankar; N Sultana; C M Schonhoff; P Mitra; W Poluha; S Lambert; P J Quesenberry; N S Litofsky; L D Recht; R Nabi; S J Miller; S Ohta; B G Neel; A H Ross
Journal:  J Neurosci       Date:  2000-02-15       Impact factor: 6.167

Review 2.  Dysplastic gangliocytoma (Lhermitte-Duclos disease) associated with Cowden disease: report of a case and review of the literature for the genetic relationship between the two diseases.

Authors:  J Murata; M Tada; Y Sawamura; K Mitsumori; H Abe; K Nagashima
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

3.  P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase.

Authors:  M P Myers; J P Stolarov; C Eng; J Li; S I Wang; M H Wigler; R Parsons; N K Tonks
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 4.  Hamartomatous polyposis syndromes.

Authors:  Daniel Calva; James R Howe
Journal:  Surg Clin North Am       Date:  2008-08       Impact factor: 2.741

5.  PTEN and prostate cancer.

Authors:  E A Facher; J C Law
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

6.  PTEN: sometimes taking it off can be better than putting it on.

Authors:  M P Myers; N K Tonks
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

7.  Cowden Syndrome.

Authors:  C Eng
Journal:  J Genet Couns       Date:  1997-06       Impact factor: 2.537

Review 8.  Genetics of skin appendage neoplasms and related syndromes.

Authors:  D A Lee; M E Grossman; P Schneiderman; J T Celebi
Journal:  J Med Genet       Date:  2005-11       Impact factor: 6.318

Review 9.  A developmental and genetic classification for midbrain-hindbrain malformations.

Authors:  A James Barkovich; Kathleen J Millen; William B Dobyns
Journal:  Brain       Date:  2009-12       Impact factor: 13.501

10.  Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adults.

Authors:  Xiao-Ping Zhou; Deborah J Marsh; Carl D Morrison; Abhik R Chaudhury; Marius Maxwell; Guido Reifenberger; Charis Eng
Journal:  Am J Hum Genet       Date:  2003-10-17       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.